John Hession To Speak At MassBio

Morse corporate partner John Hession, will moderate two upcoming programs for MassBio. The first program, Communicating Effectively to Get to the Next Level of Greatness, will take place on October 23, 2019 from 8:00 AM to 10:00 AM at the MassBio Offices. Read a brief description of the program below: "Research shows that 9 out …

Continue reading John Hession To Speak At MassBio

John Hession Speaking on CFIUS and Cross-Border Biotech Transactions

At the April 9th MassBio event Cross-Border Biotech Transactions: CFIUS and Other Risks, corporate partner John Hession will speak on the risks that early-stage biotech companies face when pursuing strategic alliances with foreign partners or investors. The discussion will center around the Committee on Foreign Investment in the United States' (CFIUS) expansion of its regulation …

Continue reading John Hession Speaking on CFIUS and Cross-Border Biotech Transactions

Register today: Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances 

  The MBBP Life Sciences group will host the panel event Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances on Wednesday, April 3 in our Waltham office. Topics will include upfront license fees, technology access payments, milestone triggers, commercial due diligence fees, clinical trial milestones, royalty rates, and more. …

Continue reading Register today: Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances 

Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Due to overwhelming demand for our April 28 "Strategic Alliances: Pot of Gold or Pretty Poison?" event, we will be holding another round on Wednesday, June 28 at the Cambridge Innovation Center (CIC). Moderated by corporate attorney John Hession, a panel of business development experts will explore various research and collaboration structures, from options to license to comprehensive …

Continue reading Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Panel 3 of Life Sciences Series To Be Held On September 22nd!

On Thursday, September 22nd, MBBP will host the third panel of our Life Sciences Series, "Funding Models in Biotech".  The panel will be held at the Cambridge Innovation Center (CIC) from 4:30pm - 6:00pm. The panel will discuss today's financing environment for emerging biotech companies, and the many complexities facing these companies in their attempts …

Continue reading Panel 3 of Life Sciences Series To Be Held On September 22nd!

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Managing Partner Lisa Warren Moderating Entrepreneur’s University: Acquiring IP

Lisa Warren will be serving as a Co-Moderator for the upcoming, "Entrepreneur's University: Acquiring IP" program organized by MassBio Entrepreneur's University Working Group. Entrepreneur University hosts forums to help entrepreneurs thrive in today's competitive biotech environment.  During this program specifically, industry experts will share critical advice for entrepreneurs who are setting out to acquire their intellectual property. The …

Continue reading Managing Partner Lisa Warren Moderating Entrepreneur’s University: Acquiring IP

Boston Growing Hub for the Life Sciences Industry

The Boston Business Journal just announced that at the annual Biotechnology Innovation Organization meeting, Boston was recognized as the city with the largest number of employers in the field of research testing and medical laboratories.  The BBJ explains that from biotech giants such as Biogen to Genzyme to research labs at the prestigious Harvard and MIT, …

Continue reading Boston Growing Hub for the Life Sciences Industry

MBBP Client Selvita Establishes First U.S. Operations in Greater Boston Area

MBBP client, Selvita, recently announced an expansion into the Boston-area biotechnology and pharmaceutical market, as they open a fully-owned US subsidiary, Selvita Inc., headquartered in Cambridge, Massachusetts. Selvita is a leading global drug discovery company and the largest drug discovery company in Central and Eastern Europe. The new office, located at 485 Massachusetts Ave., will focus …

Continue reading MBBP Client Selvita Establishes First U.S. Operations in Greater Boston Area